C4X Discovery Holdings making "slight pivot" to anti-inflammatory treatments
News release
by
C4X Discovery Holdings PLC
London, UK
|
April 28, 2023 03:00 AM Eastern Daylight Time
C4X Discovery Holdings PLC (AIM:C4XD) CEO Clive Dix speaks to Thomas Warner from Proactive after releasing half-year results for the six months ending 31 January 2023. Dix gives his highlights from the interim results before turning his focus to what he describes as a "slight pivot" to anti-inflammatory treatments.
C4X has a portfolio of anti-inflammatory targets, including a molecule for COPD, and four or five new anti-inflammatory targets in the pipeline, which will be revealed in due course.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
